| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anaptysbio, Inc. (ANAB) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 37 sells. ANAB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 506.9K | $26.17M | - | |
| Other | 42.1K | $2.17M | - | |
| Dir | 39.7K | $2.05M | - | |
| CFO | 25.8K | $1.33M | - | |
| CFO | 21.9K | $1.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2018 | Londei Marco | Chief Medical Officer | Sale+OE | 30,048 | $66.76 | $2,005,855.68 | -4.6% | |
| Dec 14, 2018 | Suria Hamza68 | President, CEO | Sale+OE | 41,728 | $69.36 | $2,894,375.08 | -26.6% | |
| Dec 12, 2018 | Suria Hamza68 | President, CEO | Sale+OE | 65,585 | $71.47 | $4,687,413.22 | -19.4% | |
| Dec 3, 2018 | Piscitelli Dominic53 | Chief Financial Officer | Sale+OE | 37,000 | $72.14 | $2,669,157.50 | -35.5% | |
| Apr 16, 2018 | Lydon Nicholas | Director | Sell | 33,000 | $86.88 | $2,866,912.66 | -1.6% | |
| Aug 21, 2017 | Novo Holdings A/s58 | 10% Owner | Sell | 356,300 | $21.10 | $7,518,250.67 | -15.5% | |
| Aug 15, 2017 | Novo Holdings A/s58 | 10% Owner | Sell | 178,600 | $21.16 | $3,778,480.84 | -3.6% | |
| Aug 7, 2017 | Novo Holdings A/s58 | 10% Owner | Sell | 491,294 | $21.12 | $10,377,405.58 | -5.9% | |
| Aug 3, 2017 | Novo Holdings A/s58 | 10% Owner | Sell | 70,706 | $23.31 | $1,647,946.61 | -0.8% | |
| Jul 26, 2017 | Avalon Ventures VII L P | 10% Owner | Sell | 37,040 | $24.35 | $901,924.00 | -100% |